CVAILGOct 13, 2024

Improving 3D Few-Shot Segmentation with Inference-Time Pseudo-Labeling

arXiv:2410.09967v1h-index: 20
Originality Incremental advance
AI Analysis

This work addresses the challenge of segmenting novel classes with limited annotated data in medical imaging, offering an incremental improvement over existing few-shot segmentation methods.

The paper tackles the problem of 3D few-shot segmentation in medical imaging by leveraging query data during inference, resulting in improved segmentation accuracy across diverse datasets.

In recent years, few-shot segmentation (FSS) models have emerged as a promising approach in medical imaging analysis, offering remarkable adaptability to segment novel classes with limited annotated data. Existing approaches to few-shot segmentation have often overlooked the potential of the query itself, failing to fully utilize the valuable information it contains. However, treating the query as unlabeled data provides an opportunity to enhance prediction accuracy. Specifically in the domain of medical imaging, the volumetric structure of queries offers a considerable source of valuable information that can be used to improve the target slice segmentation. In this work, we present a novel strategy to efficiently leverage the intrinsic information of the query sample for final segmentation during inference. First, we use the support slices from a reference volume to generate an initial segmentation score for the query slices through a prototypical approach. Subsequently, we apply a confidence-aware pseudo-labeling procedure to transfer the most informative parts of query slices to the support set. The final prediction is performed based on the new expanded support set, enabling the prediction of a more accurate segmentation mask for the query volume. Extensive experiments show that the proposed method can effectively boost performance across diverse settings and datasets.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes